ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,661Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 307

$752K Total Retail Price of All Prescriptions

Rank: 17 out of 307

384 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 384 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

11% of this provider’s 384 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,673 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 444 400 1 4
OMEPRAZOLE 410 350 2 1
AMLODIPINE BESYLATE 378 318 3 3
LEVOTHYROXINE SODIUM 343 297 4 7
DONEPEZIL HCL 308 287 5 37
WARFARIN SODIUM 287 242 6 14
FENTANYL 283 236 S2 7 67
OXYCODONE-ACETAMINOPHEN 263 153 S2 8 38
SIMVASTATIN 251 219 9 5
LISINOPRIL 249 241 10 6
METOPROLOL TARTRATE 221 217 11 9
CARVEDILOL 200 149 12 12
METOPROLOL SUCCINATE 187 162 13 11
HYDROCODONE-ACETAMINOPHEN 184 168 S3 14 2
KLOR-CON M20 181 171 15 98
ESCITALOPRAM OXALATE 162 136 16 90
GENERLAC 161 145 17 245
GABAPENTIN 147 135 18 8
ATORVASTATIN CALCIUM 145 124 19 17
TRAMADOL HCL 144 124 20 16
NOVOLIN R 142 91 21 168
PANTOPRAZOLE SODIUM 131 104 22 31
ZOLPIDEM TARTRATE 131 99 22 20
AZITHROMYCIN 131 119 22 71
GLIPIZIDE 126 123 25 116
SERTRALINE HCL 126 123 25 29
POTASSIUM CHLORIDE 121 107 27 13
DIOVAN 114 80 28 50
IPRATROPIUM-ALBUTEROL 110 89 29 235
ENULOSE 108 100 30 323
NAMENDA 106 106 31 43
ALLOPURINOL 103 95 32 39
FAMOTIDINE 100 96 33 128
CLOPIDOGREL 98 88 34 27
LOSARTAN POTASSIUM 95 80 35 22
MIRTAZAPINE 94 69 36 57
PREDNISONE 92 57 37 19
LANTUS SOLOSTAR 92 55 37 178
TRAZODONE HCL 89 80 39 34
HYDRALAZINE HCL 85 70 40 73
NEXIUM 85 73 40 21
NITROFURANTOIN MONO-MACRO 84 84 42 148
OXYBUTYNIN CHLORIDE ER 78 60 43 157
METOCLOPRAMIDE HCL 77 58 44 176
QUETIAPINE FUMARATE 74 61 45 75
RANITIDINE HCL 73 72 46 93
NOVOLIN N 72 51 47 359
METFORMIN HCL 72 55 47 15
AGGRENOX 71 64 49 362
PLAVIX 70 59 50 52
CITALOPRAM HBR 70 70 50 28
BACLOFEN 70 46 50 129
RISPERIDONE 68 55 53 33
HYDROCHLOROTHIAZIDE 67 46 54 18
CEPHALEXIN 67 66 54 46
ADVAIR DISKUS 67 54 54 60
DIGOXIN 63 62 57 81
TRAVATAN Z 63 63 57 56
CLONIDINE HCL 62 28 59 44
HUMULIN N 62 55 59 373
LATANOPROST 58 58 61 32
PROMETHAZINE HCL 58 45 R 61 135
CIPROFLOXACIN HCL 56 54 63 35
TAMSULOSIN HCL 56 31 63 10
DILTIAZEM 24HR CD 55 54 65 119
ROPINIROLE HCL 54 44 66 140
PHENYTOIN 53 53 67 399
LEXAPRO 53 49 67 269
FENOFIBRATE 52 48 69 245
LYRICA 51 51 70 103
LOVAZA 50 50 71 224
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.